# An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

> **NCT06237426** · PHASE2 · COMPLETED · sponsor: **Transcend Therapeutics** · enrollment: 44 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Methylone

## Key facts

- **NCT ID:** NCT06237426
- **Lead sponsor:** Transcend Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-06
- **Primary completion:** 2025-10-06
- **Final completion:** 2025-10-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237426, "An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06237426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*